Meet Ellen Manzullo, M.D.
Ellen Manzullo, M.D., F.A.C.P.
Department of General Internal Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Division of Internal Medicine Wellness-Lead, The University of Texas MD Anderson Cancer Center
Robert Gagel MD Endowment-Steward, The University of Texas MD Anderson Cancer Center, Houston, Texas
Internal Medicine, Cancer Network, Executive Director, The University of Texas MD Anderson Cancer Center
Deputy Division Head (Clinical), The University of Texas MD Anderson Cancer Center
Professor of Medicine (NTCA), General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1986 | The University of Texas Medical School at Houston, Houston, Texas, US, Doctor of Medicine |
| 1982 | St. Mary's University, San Antonio, Texas, US, Bachelor of Science |
Postgraduate Training
| 2024-2024 | Physician Well-being Director Course, Stanford Medical School |
| 2024-2024 | LEADing Teams Accelerate Course, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2022-2023 | LEADing Teams Core Cohort, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2015 | Certificate in Health Care Management, Rice University, Houston, Texas |
| 2005-2006 | Faculty Leadership Academy Course, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2005-2005 | Mini-Advanced Training Program in Health Care Delivery Course, Intermountain Health Care Institute, Salt Lake City, Utah |
| 1999-2000 | Executive Excellence Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1987-1989 | Clinical Residency, The University of Texas Medical School, Houston, Texas |
| 1986-1987 | Clinical Internship, The University of Texas Medical School, Houston, Texas |
Licenses & Certifications
| 2024 | Mississippi Medical License |
| 2024 | Washington Medical License |
| 2024 | Georgia Medical License |
| 2024 | Oklahoma Medical License |
| 2024 | Arizona Medical License |
| 2024 | Louisiana Medical License |
| 2024 | Alabama Medical License |
| 2024 | Tennessee Medical License |
| 2022 | Recertification-American Board of Internal Medicine |
| 2021 | Florida Medical License |
| 1990 | American Board of Internal Medicine |
| 1987 | Texas Medical License |
Experience & Service
Faculty Academic Appointments
Associate Internist & Associate Professor of Medicine (NTCA), The University of Texas MD Anderson Cancer Center, Houston, Texas, 2003 - 2004
Associate Internist & Associate Professor of Medicine (TT), The University of Texas MD Anderson Cancer Center, Houston, Texas, 1999 - 2003
Associate Internist & Associate Professor of Medicine (NTCA), The University of Texas MD Anderson Cancer Center, Houston, Texas, 1998 - 1999
Associate Internist & Assistant Professor of Medicine (NTCA), The University of Texas MD Anderson Cancer Center, Houston, Texas, 1995 - 1998
Assistant Internist & Assistant Professor of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 1992 - 2003
Assistant Internist & Assistant Professor of Medicine (NTCA),, The University of Texas MD Anderson Cancer Center, Houston, Texas, 1992 - 1995
Joint Appointment in Employee Health Services (NTCA), The University of Texas M. D. Anderson Cancer Center, 1989 - 1992
Assistant Internist & Instructor in Medicine (NTCA), The University of Texas M. D. Anderson Cancer Center, Houston, Texas, 1989 - 1991
Administrative Appointments/Responsibilities
Division of Internal Medicine Wellness Lead, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present
Executive Director, Internal Medicine, Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - Present
Deputy Division Head (Clinical), Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2011 - Present
Deputy Department Chair, General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2005 - 2024
Section Chief General Internal Medicine, Department General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2005 - 2016
Associate Medical Director, Ambulatory Treatment Center, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 1997 - 2016
Associate Coordinator, Medical Oncology Teaching Service, Clinical Residents, The University of Texas MD Anderson Cancer Center, 1993 - 1994
Physician Peer Reviewer, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 1992 - 2001
Extramural Institutional Committee Activities
member, Division of Internal Medicine Advance Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Co-Chair, Search Committee GU Radiation Oncology Department, The University of Texas MD Anderson Cancer Center, 2024 - 2025
Member, Cancer Network Education Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Chair, Cancer Network Adjunct Appointment Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Ambassador, Division of Internal Medicine Diversity, Equity & Inclusion, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member, Division of Internal Medicine Education Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Lead, Division of Internal Medicine Wellness, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Division of Internal Medicine Education Portfolio Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Reviewer, 2020 Distinguished Faculty Mentor Awards Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2020
Member, Cancer Network Adjunct Appointment Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2022
Member, Survivorship Operational Priority Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2020
Member, Advisory Committee for Advanced Metastatic Breast Cancer Program, The University of Texas MD Anderson Cancer Center, 2019 - Present
Founding Member, Division of Internal Medicine Women for Women Organization, The University of Texas MD Anderson Cancer Center, 2018 - 2023
Member, Institutional Faculty Administrator Oncall, The University of Texas MD Anderson Cancer Center, 2017 - Present
Associate Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2019
Key Interviewer, Head and Neck Surgery Department Chair Candidates, The University of Texas MD Anderson Cancer Center, 2017 - 2017
Member, Faculty Mentoring Advisory Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2019
Distinguished Clinical Faculty Mentor Award, Selection Committee, 2016 Provost's Distinguished Clinical Faculty Mentor Award, The University of Texas MD Anderson Cancer Center, 2016 - Present
Co-Chair, Cancer Network Resource Utilization Institutional Visits Workgroup, The University of Texas MD Anderson Cancer Center, 2015 - 2015
Member, Regional Care Faculty Contracts Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2016
Member, Medical Quality Planning Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2019
Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2017
Alternate Member (nominated by Dr. DePinho), Negotiated Rulemaking Committee on Resident Physician Expansion Program, Texas Higher Education Coordinating Board, The University of Texas MD Anderson Cancer Center, 2014 - 2014
Ex-Officio Member, PRS Executive Council, The University of Texas MD Anderson Cancer Center, 2013 - Present
Chair, PRS Physician Compensation & Benefit Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Council of Division Committees on Gender Inclusiveness, The University of Texas MD Anderson Cancer Center, 2013 - 2020
Member, Integrative Health Working Group, The University of Texas MD Anderson Cancer Center, 2013 - 2016
Member, AD Hoc Quality Planning Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Immediate Past Chair, Executive Committee of Medical Staff, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Member, National Clinical Expansion Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Selection Committee Member, Ethel Fleming Arceneaux Outstanding Nurse Oncologist Award, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Member, Survivorship Research Advisory Workgroup, The University of Texas MD Anderson Cancer Center, 2010 - 2023
Member, Search Committee for Transfusion Medicine faculty, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Member, Twenty-Four Hour Medical Coverage Steering Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Selection Committee Member, Ethel Fleming Arceneaux Outstanding Nurse Oncologist Award, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Member, Institutional OPPE Workgroup, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Chair, Executive Committee Medical Staff, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Member, President's Advisory Board, The University of Texas MD Anderson Cancer Center, 2009 - 2011
Member, Cancer Survivorship Education Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present
Member, Search Committee for Chair of Psychiatry, The University of Texas M. D. Anderson Cancer Center and Baylor College of Medicine, The University of Texas MD Anderson Cancer Center, 2008 - 2009
Member, Division of Internal Medicine Quality Council, The University of Texas MD Anderson Cancer Center, 2007 - 2009
Chair-Elect, Executive Committee Medical Staff, The University of Texas MD Anderson Cancer Center, 2006 - 2009
Member, American College of Surgeons (ACOS) - Commission on Cancer Site Visit Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2006
Member, Search Committee for Chief of Clinical Ethics Section, The University of Texas MD Anderson Cancer Center, 2006 - 2006
Member, Medical Staff Bylaws Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2022
Chairman, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2007
Member, Laboratory Medicine Search Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2005
At-Large Member, Executive Committee Medical Staff, The University of Texas MD Anderson Cancer Center, 2004 - 2006
Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2005
Member, JCAHO Medical Staff Focus Group, The University of Texas MD Anderson Cancer Center, 2004 - 2004
Member, Clinical and Translational Research Center Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2005
Member, Patient Safety Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2014
Chairman, Medical Record Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2007
Member, Clinical Ethics Committee Nominations Subcommittee, The University of Texas MD Anderson Cancer Center, 2003 - 2004
Member, Ethics Committee, The University of Texas MD Anderson Cancer Center, 2002 - 2005
Member, Discharge Process Collaborative, The University of Texas MD Anderson Cancer Center, 2002 - 2003
Member, Interdisciplinary Documentation Committee, The University of Texas MD Anderson Cancer Center, 2002 - 2007
Member, Close Call Reporting System Advisory Committee, The University of Texas MD Anderson Cancer Center, 2002 - 2005
Member, Executive Committee of Medical Staff (at Large Member), The University of Texas MD Anderson Cancer Center, 2000 - 2003
Member, Subcommittee for Selection of Faculty Achievement Awards In Patient Care, The University of Texas MD Anderson Cancer Center, 2000 - 2001
Chairman, M. D. Anderson Physician Network Quality Council, The University of Texas MD Anderson Cancer Center, 1999 - 2010
Member, Quality Council, The University of Texas MD Anderson Cancer Center, 1999 - 2009
Member, Subcommittee for Selection of Faculty Achievement Awards in Patient Care, The University of Texas MD Anderson Cancer Center, 1999 - 2000
Member, Executive Committee Faculty Senate, The University of Texas MD Anderson Cancer Center, 1999 - 2001
Member, Institutional Risk Management Committee, The University of Texas MD Anderson Cancer Center, 1998 - 2000
Member, ATC Chemotherapy & Infusion Units Customer Service Advisory Group, The University of Texas MD Anderson Cancer Center, 1998 - 2000
Vice-Chairman, Medical Records Committee, The University of Texas MD Anderson Cancer Center, 1997 - 2003
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 1997 - 2001
Member, Tenure Issues Subcommittee Faculty Senate, The University of Texas MD Anderson Cancer Center, 1997 - 2001
Member, M. D. Anderson Physician Network Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 1997 - 1999
Member, Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 1996 - 1999
Member, Executive Steering Committee Materials Use Evaluation, The University of Texas MD Anderson Cancer Center, 1996 - 1999
Co-Chairperson, Materials Use Evaluation/Review Program (Medical/Surgical), The University of Texas MD Anderson Cancer Center, 1995 - 1999
Member, Institutional Risk Management Committee, The University of Texas MD Anderson Cancer Center, 1994 - 1996
Alternate, Surveillance Committee, The University of Texas MD Anderson Cancer Center, 1994 - 1995
Alternate, Disaster Subcommittee, The University of Texas MD Anderson Cancer Center, 1994 - 1995
Alternate, Faculty Senate Committee, The University of Texas MD Anderson Cancer Center, 1993 - 1995
Member, Team Anderson Program Committee Volunteer, The University of Texas MD Anderson Cancer Center, 1993 - 1994
Member, Sick Leave Pool Committee, The University of Texas MD Anderson Cancer Center, 1992 - 1999
Member, Medical Records Committee, The University of Texas MD Anderson Cancer Center, 1992 - 1997
Alternate Member, Institutional Risk Management Coordinating Committee, The University of Texas MD Anderson Cancer Center, 1990 - 1991
Editorial Activities
Editorial Consultant, American College of Physicians PIER (Physicians Information and Educational Resources), 2005 - 2015
Honors & Awards
| 2026 - Present | CASTLE CONNOLLY RECOGNIZED DOCTORS 2026 |
| 2026 | 2026 Exceptional Women in Medicine |
| 2022 | 2022 Robert F. Gagel Lifetime Achievement Award, Division of Internal Medicine, MD Anderson Cancer Center |
| 2021 - 2023 | America's Most Honored Doctors |
| 2021 | Who's Who in America |
| 2019 | America's Most Honored Professionals - Top 1% |
| 2018 | Nominated for the University of Texas System Kenneth I. Shine, MD Academy of Health Science Education |
| 2017 - 2025 | 2025 Castle Connolly Exceptional Women in Medicine, Castle Connolly Exceptional Women in Medicine |
| 2017 - 2020 | America's Most Honored Professionals |
| 2017 - 2018 | America's Most Honored Professionals - Top 5% |
| 2017 | 2017 MD Anderson Distinguished Clinical Faculty Mentoring Nominee, The University of Texas M.D. Anderson Cancer Center |
| 2017 | President's Award for Faculty Excellence in Network Development, The University of Texas M.D. Anderson Cancer Center |
| 2016 | Samuel J. Hassenbusch III MD, PhD PRS Leadership and Institutional Service Award, The University of Texas M.D. Anderson Cancer Center |
| 2015 | Top Reviewer, Annals of Internal Medicine |
| 2014 | Finalist, Julie & Ben Rogers Award for Excellence in Patient Care |
| 2014 | Doctor of Excellence, Board of the Leaders in Healthcare Network |
| 2014 | America's Top Physician |
| 2014 | Doctor of Excellence, Board of the Leaders in Healthcare Network |
| 2012 - 2025 | Castle Connolly Top Doctor |
| 2012 - 2013 | US News Top Doctor |
| 2008 | Fellow, Clinical Safety and Effectiveness, The University of Texas M. D. Anderson Cancer Center |
| 2005 - Present | Multi-year Appointment Award, The University of Texas M. D. Anderson Center |
| 2003 - 2012 | General Internal Medicine Preceptorship Award 2012, American College of Physicians, Texas Chapter |
| 2000 | Physician's Recognition Award, American Medical Association |
| 1995 | Fellow, American College of Physicians |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2018. Chronic Fatigue. Conference. Chronic Fatigue. Houston, TX, US.
- 2011. Cancer-Related Fatigue and Management Strategies. Conference. Cancer-Related Fatigue and Management Strategies. Houston, TX, US.
- 2001. Oncologic Emergencies. Conference. Oncologic Emergencies. Houston, TX, US.
Regional Presentations
- 2005. Reducing The Number of Surgical Cases Canceled The Day of Surgery. Conference. Reducing The Number of Surgical Cases Canceled The Day of Surgery. Crowne Plaza-Medical Center, Houston, TX, US.
National Presentations
- 2025. Cancer Related Fatigue. Invited. Lecture to Rush; Cancer Rehabilitation Fellows and PMR Residency. Houston, Texas, US.
- 2025. The Fatigue of Immunotherapy: A Comprehensive Review. Poster. MASCC/ISOO Annual Meeting 2025. Seattle, Washington, US.
- 2023. Linking Internal Medicine Care to Metastatic Breast Cancer Patients for Success: LIMBS. Conference. Updates on Advanced Breast Cancer: Local Management and Other New Perspectives. Houston, TX, US.
- 2019. "Internal Medicine for the Cancer Patient". Conference. "Internal Medicine for the Cancer Patient". Houston, TX, US.
- 2016. Onco-Internal Medicine (Breakout Session). Conference. Third Annual M.D. Anderson Cancer Center Partner Meeting. Houston, TX, US.
- 2015. Cancer Related Fatigue. Conference. Third Biennial Advances in Cancer Survivorship Practice: A Conference for Health Care Professionals. Houston, TX, US.
- 2013. Cancer Related Fatigue and Sleep Disorders (Breakout Session for Survivorship Program Development). Conference. Advances in Cancer Survivorship Practice: A Conference for Health Care Professionals. Houston, TX, US.
- 2011. Sleep Disorders in Cancer Patients with Fatigue: The Role of Sleep Apnea. Conference. Survivorship Research Symposium. Houston, TX, US.
- 2009. The General Internist and The Cancer Survivor (Breakout Session). Conference. Medical Issues in Cancer Survivors Conference. Houston, TX, US.
- 2008. Oncologic Emergencies. Conference. Fourth Annual Symposium Achieving Excellence: Oncology Nursing Across the Continuum of Care. Boston, MA, US.
- 2008. Cancer-Related Fatigue. Conference. Fourth Annual Symposium Achieving Excellence: Oncology Nursing Across the Continuum of Care. Boston, MA, US.
- 2006. Perioperative Risk Assessment. Conference. Oncologic Dentistry and Maxillofacial Prosthetics Symposium. Houston, TX, US.
- 2004. Neutropenic Fever. Conference. 4th Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
- 2003. Update in Perioperative Medicine. Conference. 51st Meeting of the American Academy of Maxillofacial Prosthetics. Scottsdale, AZ, US.
- 2003. Perioperative Medical Evaluation of the Head and Neck Cancer Patient. Conference. Oncologic Dentistry and Maxillofacial Prosthetics Symposium. Houston, TX, US.
- 2000. A Man with Acute Renal Failure and an Abdominal Mass. Conference. 94th Annual Scientific Assembly Southern Medical Association. Orlando, FL, US.
- 1996. The Compromised Nature of the Cancer Patient. Conference. 78th Annual Meeting of the American Association of Oral and Maxillofacial Surgeons. Miami, FL, US.
- 1995. Common Oncologic Emergencies. Conference. Eighth Annual Cancer Symposium. Coffeyville, KS, US.
International Presentations
- 2024. Preparing for The Future: Outcomes of An Oncologic Focused Internal Medicine Residency Program, Multinational Associates of Supportive Care Cancer. Poster. MASCC. Lille, FR.
- 2022. "Continued Robust Interest in a Novel Oncologic Focused Internal Medicine Residency Program". Conference. "Continued Robust Interest in a Novel Oncologic Focused Internal Medicine Residency Program". Virtual E-Poster, US.
- 2021. "Outcomes of a Novel Oncologic-Focused Internal Medicine Residency Program". Conference. "Outcomes of a Novel Oncologic-Focused Internal Medicine Residency Program". Virtual e-poster, US.
- 2021. Cancer/Transplant-Related Fatigue: what to know, what to do. Conference. Cancer/Transplant-Related Fatigue: what to know, what to do. Virtual, US.
- 2019. "The Development of a Novel Oncologic-Focused Internal Medicine Residency Program". Conference. "The Development of a Novel Oncologic-Focused Internal Medicine Residency Program". San Francisco, US.
- 2018. Parallel Session, "Education for a better Chemotherapy Experience - Challenge of Patient Education and Risk of Thrombosis with Prevention Strategies". Conference. Parallel Session, "Education for a better Chemotherapy Experience - Challenge of Patient Education and Risk of Thrombosis with Prevention Strategies". Vienna, AT.
- 2018. Cancer Related Fatigue and Moderator Breakout Session (Colon Cancer), "Leveraging Health IT for the Medical Care of Cancer Survivors Workshop,". Conference. Cancer Related Fatigue and Moderator Breakout Session (Colon Cancer), "Leveraging Health IT for the Medical Care of Cancer Survivors Workshop,". Denver, US.
- 2017. Sleep Disorders and Cancer. Conference. Multinational Association of Supportive Care in Cancer (MASCC). Washington DC, US.
- 2016. Sleep Disorders and Cancer. Conference. Multinational Association of Supportive Care in Cancer (MASCC). Adelaide, AU.
- 2015. Daytime Sleepiness Contributes To Cancer-Related Fatigue In Breast Cancer Survivors: A Case Report. Conference. Multinational Association of Supportive Care in Cancer. Copenhagen, DK.
- 2012. Age Effects on Sleep Architecture in Patients with Cancer-Related Fatigue (CRF). Conference. Multinational Association of Supportive Care in Cancer. New York, US.
- 2010. Sleep Disorders Should be Considered in Patients with Cancer-Related Fatigue. Conference. Multinational Association of Supportive Care in Cancer. Vancouver, CA.
- 2003. Mucositis: Predictor of Outpatient Failure in Febrile Neutropenia. Conference. Multinational Association of Supportive Care in Cancer. Berlin, DE.
- 1999. Infection and Colonization Associated with Oral and Gastrointestinal Mucositis in Patients with Cancer. Conference. Multinational Association of Supportive Care in Cancer. Nice, FR.
- 1998. Outcomes and Resource Utilization in Cancer Patients with Oral and Gastrointestinal Complications of Chemotherapy. Conference. Annual Meeting of the American Society of Clinical Oncology. Los Angeles, US.
- 1998. Incidence and Patterns of Care of Oral and Gastrointestinal Mucositis in Cancer Patients. Conference. Multinational Association of Supportive Care in Cancer. San Antonio, US.
- 1994. Outpatient Parenteral Acyclovir Therapy for Varicella-Zoster Virus Infection in Cancer Patients. Conference. 30th Annual Meeting of the American Society of Clinical Oncology. Dallas, US.
Formal Peers
- 2013. Cancer-Related Fatigue and Sleep Disorders. Invited. Phoenix, AZ, US.
- 2011. Cancer-Related Fatigue. Invited. Phoenix, AZ, US.
- 2002. Oncologic Emergencies. Invited. Houston, TX, US.
- 2002. Oncologic Emergencies. Invited. Wharton, TX, US.
- 2001. Oncologic Emergencies. Invited. Pasadena, TX, US.
- 1998. Oncologic Emergencies. Invited. San Antonio, TX, US.
- 1997. Cervical Cancer. Invited. Houston, TX, US.
- 1997. Oncologic Emergencies. Invited. Cleveland, OH, US.
- 1996. Cancer Screening and Prevention. Invited. Houston, TX, US.
- 1996. Cancer Prevention and Detection: Lung Cancer and Skin Cancer. Invited. Beaumont, TX, US.
- 1994. Medical Oncologic Emergencies. Invited. Corpus Christi, TX, US.
- 1993. Emergencies in Medical Oncology. Invited. Corpus Christi, TX, US.
- 1992. Preoperative Evaluation. Invited. Houston, TX, US.
Grant & Contract Support
| Date: | 2015 |
| Title: | Medical Issues in Cancer Patients and Survivors |
| Funding Source: | Genentech |
| Role: | Program Leader |
| Date: | 2015 |
| Title: | Medical Issues in Cancer Patients and Survivors |
| Funding Source: | Pfizer |
| Role: | Program Leader |
| Date: | 2015 |
| Title: | Medical Issues in Cancer Patients and Survivors |
| Funding Source: | Sigma Tau Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2015 |
| Title: | Medical Issues in Cancer Patients and Survivors |
| Funding Source: | Bristol Myers Squibb |
| Role: | Program Leader |
| Date: | 2013 |
| Title: | Medical Issues in Cancer Patients and Survivors |
| Funding Source: | Amgen USA |
| Role: | Program Leader |
| Date: | 2013 |
| Title: | Medical Issues in Cancer Patients and Survivors |
| Funding Source: | Teva Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2013 |
| Title: | Medical Issues in Cancer Patients and Survivors |
| Funding Source: | Novartis Pharmaceuticals, Inc |
| Role: | Program Leader |
| Date: | 2008 - 2009 |
| Title: | Medical Issues in Cancer Survivors Conference |
| Funding Source: | Amgen |
| Role: | Program Leader |
| Date: | 2008 - 2009 |
| Title: | Medical Issues in Cancer Survivors Conference |
| Funding Source: | Sanofi-Aventis |
| Role: | Program Leader |
| Date: | 2008 - 2009 |
| Title: | Medical Issues in Cancer Survivors Conference |
| Funding Source: | Bristol-Myers Squibb |
| Role: | Program Leader |
| Date: | 2008 - 2009 |
| Title: | Medical Issues in Cancer Survivors Conference |
| Funding Source: | Pfizer |
| Role: | Program Leader |
| Date: | 2008 - 2009 |
| Title: | Medical Issues in Cancer Survivors Conference |
| Funding Source: | Genentech |
| Role: | Program Leader |
| Date: | 2008 - 2009 |
| Title: | Medical Issues in Cancer Survivors Conference |
| Funding Source: | AstraZeneca |
| Role: | Program Leader |
| Date: | 2006 - 2006 |
| Title: | Oncologic Emergencies 2006 |
| Funding Source: | Sanofi Aventis Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2006 - 2006 |
| Title: | Oncologic Emergencies 2006 |
| Funding Source: | Amgen |
| Role: | Program Leader |
| Date: | 2006 - 2006 |
| Title: | Oncologic Emergencies 2006 |
| Funding Source: | OrthoMcNeil |
| Role: | Program Leader |
| Date: | 2006 - 2006 |
| Title: | Oncologic Emergencies 2006 |
| Funding Source: | Elan Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2006 - 2006 |
| Title: | Oncologic Emergencies 2006 |
| Funding Source: | University Cancer Funds (UCF) |
| Role: | Program Leader |
| Date: | 2006 - 2006 |
| Title: | Oncologic Emergencies 2006 |
| Funding Source: | Merck & Co., Inc |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Elan Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Amgen |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | AstraZeneca |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Wyeth Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Merck & Co., Inc |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Aventis Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | P & G Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Pfizer |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Tibotec Therapeutics |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Novartis |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | Schering |
| Role: | Program Leader |
| Date: | 2004 - 2004 |
| Title: | Internal Medicine & The Cancer Patient Conference 2004 |
| Funding Source: | OrthoMcNeil |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Pfizer |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Novartis Oncology |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | B. C. Decker Inc |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Pharmion Corporation |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Ortho-McNeil Pharmaceutical Inc |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Ortho Biotech |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Amgen |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Merck & Co., Inc |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | GlaxoSmithKline |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Cephelon |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Schering |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Elan Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Aventis Pharmaceuticals |
| Role: | Program Leader |
| Date: | 2003 - 2003 |
| Title: | Oncologic Emergencies Conference 2003 |
| Funding Source: | Scios Inc |
| Role: | Program Leader |
Selected Publications
Peer-Reviewed Articles
- Manzullo EF, Faiz SA, Hamill RJ, Tweardy DJ, Sembera CA, Lahoti A, Odaro O. BCM-MD Anderson onco-medicine track: a novel internal medicine residency pathway to strengthen the supportive cancer care workforce. Support Care Cancer 34(1):41, 2025. e-Pub 2025. PMID: 41413680.
- Martinez Leal I, Pillai AB, Foreman JT, Siu KW, Heredia NI, Escalante CP, Manzullo EF, Christie AJ, Lacourt TE, Razouki ZA, Hwang JP. A Qualitative Study of the Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome. Cancers (Basel) 16(18), 2024. e-Pub 2024. PMID: 39335119.
- Martinez Leal I, Pillai AB, Foreman JT, Siu KW, Heredia NI, Escalante C, Manzullo EF, Christie AJ, Lacourt TE, Razouki ZA, Hwang JP. A Qualitative Study of Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome. Res Sq, 2023. e-Pub 2023. PMID: 37720029.
- Wu IHC, Balachandran DD, Faiz SA, Bashoura L, Escalante CP, Manzullo EF. Characteristics of Cancer-Related Fatigue and Concomitant Sleep Disturbance in Cancer Patients. J Pain Symptom Manage 63(1):e1-e8, 2022. e-Pub 2022. PMID: 34348178.
- Lacourt TE, Heijnen CJ, Manzullo EF, Escalante C. A central role for apathy in the effectiveness of interventions for cancer-related fatigue. Psychooncology 29(10):1613-1619, 2020. e-Pub 2020. PMID: 32658377.
- Lacourt TE, Vichaya EG, Escalante C, Manzullo EF, Gunn B, Hess KR, Heijnen CJ, Dantzer R. An effort expenditure perspective on cancer-related fatigue. Psychoneuroendocrinology 96:109-117, 2018. e-Pub 2018. PMID: 29929087.
- Balachandran DD, Faiz SA, Bashoura L, Manzullo EF. Cancer-related fatigue presenting with excessive daytime sleepiness. SAGE Open Med Case Rep 5:2050313X17748865, 2017. e-Pub 2017. PMID: 29318018.
- Yennurajalingam S, Reddy A, Tannir NM, Chisholm GB, Lee RT, Lopez G, Escalante CP, Manzullo EF, Frisbee Hume S, Williams JL, Cohen L, Bruera E. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report. Integr Cancer Ther 14(5):419-27, 2015. e-Pub 2015. PMID: 25873296.
- Escalante CP, Meyers MC, M Reuben PJ, Wang PX, Qiao MW, F Manzullo ME, H Alvarez MR, Khanh Morrow MP, M Gonzalez-Angulo MA, Shelley Wang MX, mendoza MT, Liu PW, Holmes MH, Hwang MJ, Pisters MK, Overman MM, Cleeland MC, PhD. A Randomized, Double-Blind, Two-Period, Placebo-Controlled Crossover Trial of Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients. Cancer Journal 20(1):8-14, 2014. e-Pub 2014. PMID: 24445757.
- Escalante CP, Kallen MA, Valdres RU, Morrow PK, Manzullo EF. Outcomes of a Cancer-Related Fatigue Clinic in a Comprehensive Cancer Center. J Pain Symptom Manage 39(4):691-701, 2010. e-Pub 2010. PMID: 20226622.
- Escalante CP, Manzullo EF, Lam TP, Ensor JE, Valdres RU, Wang XS. Fatigue and its Risk Factors in Cancer Patients Who Seek Emergency Care. J Pain Symptom Manage 36(4):358-66, 2008. e-Pub 2008. PMID: 18411011.
- Rolston KV, Manzullo EF, Elting LS, Frisbee-Hume SE, McMahon L, Theriault RL, Patel S, Benjamin RS. Once Daily, Oral, Outpatient Quinolone Monotherapy for Low-risk Cancer Patients with Fever and Neutropenia: A Pilot Study of 40 Patients Based on Validated Risk-prediction Rules. Cancer Vol. 1, No. 106(11)(11):2489-94, 2006. e-Pub 2006. PMID: 16628654.
- Escalante CP, Weiser MA, Manzullo E, Benjamin R, Rivera E, Lam T, Ho V, Valdres R, Lee EL, Badrina N, Fernandez S, DeJesus Y, Rolston K. Outcomes of Treatment Pathways in Outpatient Treatment of Low Risk Febrile Neutropenic Cancer Patients. Support Care Cancer Vol. 12(9):657-62, 2004. e-Pub 2004. PMID: 15185134.
- Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The Burdens of Cancer Therapy: Clinical and Economic Outcomes of Chemotherapy-Induced Mucositis. Cancer Vol. 98, No. 7(7):1531-9, 2003. e-Pub 2003. PMID: 14508842.
- Escalante CP, Manzullo E, Valdres R. A Cancer-Related Fatigue Clinic: Opportunities and Challenges. J Natl Compr Canc Netw Vol. 1, No. 3(3):333-343, 2003. e-Pub 2003. PMID: 19761068.
- Manzullo E, Escalante C, Weiser MA, Freedman R, Forman A. Case Report: An Elderly Woman with an Ovarian Mass and Myasthenia Gravis. Resident and Staff Physician:55-61, 2001. e-Pub 2001.
- Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Identifying Risk Factors for Imminent Death in Cancer Patients with Acute Dyspnea. Journal of Pain and Symptom Management Vol. 20, No. 5:318-25, 2000. e-Pub 2000. PMID: 11068153.
- Weiser MA, O'Brien S, Escalante C, Manzullo E. Tuberculosis Meningitis in a Patient With Acute Myelogenous Leukemia. Leukemia and Lymphoma Vol. 33, No. 1-2:187-92, 1999. e-Pub 1999. PMID: 10194137.
- Elting LS, Rubenstein EB, Kurtin D, Rolston KV, Fangtang J, Martin CG, Raad IR, Whimbey EE, Manzullo E, Bodey GP. Mississippi Mud in the Nineties: Risks and Outcomes of Vancomycin-Associated toxicity in General Oncology Practice. Cancer Vol. 83:2597-607, 1998. e-Pub 1998. PMID: 9874468.
- Escalante CP, Manzullo EF, Weiser MA, Rubenstein EB. The Generalist Finds a Niche in a Comprehensive Cancer Center: A Decade of Growth at the University of Texas M. D. Anderson Cancer Center. Cancer Control Vol. 5, No. 3:271-276, 1998. e-Pub 1998. PMID: 10761061.
- Rolston KV, Manzullo E, Elting L, Frisbee-Hume S, Rodriguez S, Rubenstein EB. Ambulatory Management of Varicella-Zoster Virus Infection in Immunocompromised Cancer Patients. Supportive Care in Cancer Vol. 6:57-62, 1998. e-Pub 1998. PMID: 9458538.
- Martin CG, Kennedy KF, Elting LS, Manzullo EF, Escalante CP, Rubenstein EB. Incidence of Emergency Visits Among Oncology Patients Receiving Outpatient Chemotherapy: Implications for Care in a Capitated Market. Cancer Control: J Moffitt Cancer Center Vol. 3, No. 5:343-49, 1996. e-Pub 1996. PMID: 10764502.
- Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, Kish SK, Manzullo EF, Rubenstein EB. Dyspnea in Cancer Patients. Etiology, Resource Utilization, and Survival-implications in a Managed Care World. Cancer Vol. 78, No. 6:1320-25, 1996. e-Pub 1996. PMID: 8826956.
- Manzullo EF, Rubenstein EB, Rolston KVI. Outpatient Management of the Febrile Neutropenic Patient with Cancer. Infections in Medicine Vol. 13, No. 5:357-69, 1996. e-Pub 1996.
Invited Articles
- Manzullo E. The MD Anderson Manual of Medical Oncology (4th ed.). McGraw Hill Education. [1], 2022. e-Pub 2022.
- Manzullo EF. Treating Cancer-Related Fatigue. Oncolog Vol. 49, No. 7-8:8, 2004. e-Pub 2004.
- Manzullo EF, Weed HG. Perioperative Issues in Patients with Cancer. Med Clin North Am Vol. 87(1):243-56, 2003. e-Pub 2003. PMID: 12575893.
- Manzullo EF, Escalante CP. Research Into Fatigue. Hematol Oncol Clin North Am Vol. 16,(3):619-28, 2002. e-Pub 2002. PMID: 12170571.
- Manzullo EF, Anderson RW. Review: Physicians Cancer Chemotherapy Drug Manual 2001. Annals of Internal Medicine Vol. 136, No. 4:340, 2002. e-Pub 2002.
- Manzullo E, David C, Manning J. Renal Failure and an Abdominal Mass in a 52-Year Old Man. Primary Care & Cancer Vol. 20, No. 4:47-50, 2000. e-Pub 2000.
- Manzullo E, Sneige N, Singletary SE, Escalante C. Diagnosis of a Breast Mass in a Young Woman. Primary Care & Cancer Vol. 18, No. 9:15-21, 1998. e-Pub 1998.
- Manzullo EF, Rubenstein EB. The Evaluation of an Implantable Peripheral Port System Placed by Physician Assistants in Cancer Patients. Topics on Supportive Care in Oncology Vol. 21:6-8, 1996. e-Pub 1996.
- Weiser MA, Frisbee-Hume S, Manzullo E, Escalante C, Rubenstein EB. Identification and Outpatient Management of the Low-Risk Febrile Neutropenic Patient with Cancer. Home HealthCare Consultant Vol. 3, No. 4:35-49, 1996. e-Pub 1996.
- Manzullo EF, Bailey S. Oncology Patients in the Emergency Room: Refusal of Treatment in the Hospital Setting. Cancer Bulletin Vol. 47, No. 4:335-38, 1995. e-Pub 1995.
Review Articles
- Potter, L, Lopez-Olivo, MA, Uppal, RS, Beeler, D, Thong, MS, Phan, B, Chou, YJ, Krause, KJ, Tanveer, A, Hussain, HU, Khan, M, Hassan, NA, Manzullo, EF, Kleckner, AS, Escalante, CP. Cancer-related fatigue during treatment with neoadjuvant and/or adjuvant immune checkpoint inhibitors. Supportive Care in Cancer 34(9), 2026. e-Pub 2026. PMID: 42554880.
- Manzullo E. Cancer-related fatigue during treatment with neoadjuvant and/or adjuvant immune checkpoint inhibitors: a systematic review and meta-analysis. Supportive Care in Cancer, 2026. e-Pub 2026.
- Escalante CP, Potter L, Bassaragh A, Manzullo E. Review of a high-resourced cancer-related fatigue clinic and considerations in lower-resourced environments. Support Care Cancer 33(11):1007, 2025. e-Pub 2025. PMID: 41175230.
- Kav S, Fleury M, Fernandez-Ortega P, Manzullo EF, Kerr KA, DeGennaro R, Ginex PK. 15 years supporting adherence to oral anti-cancer treatment: use of the MASCC Oral Agent Teaching Tool (MOATT) worldwide, a review for the future. Support Care Cancer 33(3):229, 2025. e-Pub 2025. PMID: 40014143.
- Balachandran D, Bashoura L, Manzullo E, Sheshadri A, Faiz S. The Impact of immunotherapy on sleep and circadian Rhythms in patients with Cancer. Frontiers In Oncology 13, 2023. e-Pub 2023.
- Balachandran DD, Bashoura L, Sheshadri A, Manzullo E, Faiz SA. The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer. Front Oncol 13:1295267, 2023. e-Pub 2023. PMID: 38090501.
- Rolston KV, Frisbee-Hume SE, Patel S, Manzullo EF, Benjamin RS. Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients. Support Care Cancer 18(18):89-94, 2010. e-Pub 2010. PMID: 19387695.
- Escalante CP, Manzullo EF. Cancer-Related Fatigue: The Approach and Treatment. J Gen Intern Med 24(2):412-416, 1525-1497, 2009. e-Pub 2009. PMID: 19838841.
- Manzullo E, Liu W, Escalante C. Treatment for cancer-related fatigue: an update. Expert Rev Anticancer Ther 3(1):99-106, 2003. e-Pub 2003. PMID: 12597354.
- Valdres RU, Escalante C, Manzullo E. Fatigue: a debilitating symptom. Nurs Clin North Am 36(4):685-94, vi, 2001. e-Pub 2001. PMID: 11726347.
- Manzullo EF. Sepsis: The Role of Steroids and Monoclonal Antibodies in Treatment. Oncology (Williston Park) Vol. 8, No. 6:115-20; discussion 120, 123, 1994. e-Pub 1994. PMID: 8074977.
Professional Educational Materials
- Manzullo E. Late Effects for Cancer Survivors video: Cancer Related Fatigue, 2022.
- Manzullo EF, Balachandran. Lecture: Professional Oncology Education Taping on Survivorship: Cancer Related Fatigue and Sleep (Part i), 2010.
- Burman K, Manzullo E, Yeung SC. Perioperative Management of Hyperthyroid Patients. American College of Physician's PIER (Physicians' Information and Education Resource). Peer-Reviewed, 2006.
- Manzullo E, Yeung SC. Perioperative Management of Hypothyroid Patients. American College of Physician's PIER (Physicians' Information and Education Resource). Peer-Reviewed, 2005.
- Mundy S, Manzullo E, Escalante C. Medical Backgrounder on Cancer-Related Fatigue. Timely Topics in Medicine, 2003.
Abstracts
- FrancisE, PounardjianT, LiJ, MokuP, AvidanO, DeCarliK, Manzullo E, SanftTB, McGarryK, DizonDS, DuffyCM. The Brown University cancer prevention & survivorship curriculum: A case study on program development in an internal medicine residency 41(16), 2023. e-Pub 2023.
- KalerA, RaghavendraAS, KirklinGT, CunninghamD, Manzullo E, TripathyD, RazoukiZ. Linking Internal Medicine Care to Metastatic Breast Cancer Patients for Success: LIMBS 83(5), 2023. e-Pub 2023.
- Manzullo E, HamillRJ, TweardyDJ, SemberaCA, FaizSA, LahotiA. Continued Robust Interest in a Novel Oncologic Focused Internal Medicine Residency Program 30:S39, 2022. e-Pub 2022.
- Manzullo EF, Hamill RJ, Tweardy DJ, Sembera CA, Faiz SA, Lahoti A. Outcomes of a Novel Oncologic-Focused Internal Medicine Residency Program, 2021. e-Pub 2021.
- Manzullo EF, Hamill RJ, Lahoti A, Tweardy DJ, Gagel RF. The Development of a Novel Oncologic-Focused Internal Medicine Residency Program, 2019. e-Pub 2019.
- Lam T, Richardson MN, Manzullo EF, Kallen M, Yang D, Haas NM, Escalante CP. Utilizing electronic technologies to measure patient-reported outcomes (PRO) assessment completion time 34(26_suppl):69, 2016. e-Pub 2016. PMID: 28156461.
- J Patlan J, M Perdon M, E Manzullo E, C Escalante C. Role of a Cancer Diagnosis Clinic in an Internal Medicine Residency Program 979, 2015. e-Pub 2015.
- N Brito-Dellan N, T Lam T, E Manzullo E, M Kallen M, D Yang D, N Haas N, C Escalante C. Utilizing Electronic Technologies To Measure Pro Assessment Completion Time in Clinical Practice 995, 2015. e-Pub 2015.
- D Balachandran D, C Escalante C, SA Faiz SA, L Bashoura L, B Fellman B, T Lam T, E Manzullo E. Sleep Disturbance Contributes to Cancer-Related Fatigue Cancer Patients With Active Disease 272, 2015. e-Pub 2015.
- Balachandran D, Manzullo E, Kallen MA, Holmes H, Escalante CP. Sleep Architecture in Patients with Cancer-Related Fatigue (CRF), 2012. e-Pub 2012.
- Holmes H, Manzullo E, Balachandran D, Kallen MA, Escalante CP. The Paradox of Symptom Burden in Older Patients with Cancer-Related Fatigue (CRF), 2012. e-Pub 2012.
- Manzullo E, Balachandran D, Kallen MA, Holmes H, Escalante CP. Age Effects on Sleep Architecture in Patients with Cancer-Related Fatigue (CRF), 2012. e-Pub 2012.
- Escalante CP, Manzullo E, Rodriguez S, de Achaval S, Novy DM, Suarez-Almazor ME. Collaborative Group Clinics (CGCs) for Cancer-Related Fatigue, 2011. e-Pub 2011.
- Kallen MA, Duffy J, Valdres R, Morrow PK, Manzullo E, Escalante CP. Patient Apathy and Increased Symptom Burden: Initial Experiences in a Cancer-Related Fatigue (CRF) Clinic 18(3):S95-S96 (#06-038), 2010. e-Pub 2010.
- Escalante CP, Row M, Manzullo E, Qiao W, Gao S, Yeung SJ. Fatigue in Low Risk Febrile Neutropenia (FN) Treated as Outpatients (OPs) 18(3):S94-S95, 2010. e-Pub 2010.
- Manzullo E, Kallen M, Balachandran D, Patel P, Valdres R, Escalante CP. Sleep Disorders In Cancer Patients With Fatigue: The Role of sleep Apnea 18(3):S96-S97, 2010. e-Pub 2010.
- Escalante CP, Row M, Manzullo E, Qiao W, Gao S, Yeung SJ. Fatigue in Low-Risk Febrile Neutropenia (FN) Treated as Outpatients (OPs) 7(5):195-196, 2009. e-Pub 2009.
- Oh J, Mendoza T, Cleeland C, Valdres R, Manzullo E, Escalante CP. Fatigue in Testicular Cancer Survivors 16(6):653 (#05-049), 2008. e-Pub 2008.
- Escalante CP, Kallen MA, Manzullo E, Valdres R, Lam T, Cleeland C. Too Tired to Recover? Outcomes of a Cancer-Related Fatigue (CRF) Clinic, 2008. e-Pub 2008.
- Sahai S, Wobb J, Manzullo E. The Internal Medicine Perioperative Assessment Center: An Innovation in the Perioperative Management of Medical Comorbidities at a Comprehensive Cancer Center 73 E-Supplement 1, 2006. e-Pub 2006.
- Sahai S, Porter A, Manzullo E, Andrabi T, Holmes L. Survey of Perioperative Beta-Blockade at a Comprehensive Cancer Center Volume 73 E-Supplement 1, 2006. e-Pub 2006.
- Porter A, Sahai SK, Manzullo E, Andrabi T, Holmes L. A Needs Assessment of Perioperative and Long-Term Beta-Blockade in Cancer Patients Undergoing Surgery, 2006. e-Pub 2006.
- Escalante CP, Valdres R, Lam T, Manzullo E. Febrile Cancer Patients Seeking Acute Care: How Tired are They?:791s, 2005. e-Pub 2005.
- Valdres R, Manzullo E, Escalante C. Clinical Predictors of Severe Fatigue in Solid Tumor Patients Seeking Acute Care, 2004. e-Pub 2004.
- Manzullo E, Rolston K, Escalante C. Mucositis: Predictor of Outpatient Failure in Febrile Neutropenia Vol. 11, Number 6, 2003. e-Pub 2003.
- Escalante C, Valdres R, Lam T, Yang Y, Smith T, Fernandez S, Hwang J, Manzullo E, Pham S, Smith V. Clinical Predictors of Severe Fatigue in a Cancer Centers Emergency Center (EC):757, 2003. e-Pub 2003.
- Basen-Engquist K, De Moor C, Escalante C, Wolf JK, Bodurka DC, Taylor CC, Levenback CF, Kavanagh JJ, George G, Manzullo EF. Patterns of Fatigue in Ovarian Cancer Patients Receiving Chemotherapy:743, 2003. e-Pub 2003.
- Escalante CP, Weiser MA, Manzullo EF, Lam T, Ho V, Valdres R, Lee EL, Badrina N, Fernandez S, DeJesus Y, Benjamin RS, Rivera E, Rolston K. Outcomes in Outpatient Treatment of Low Risk Febrile Neutropenic Cancer Patients:249a, 2002. e-Pub 2002.
- Elting LS, Cooksley C, Chambers C, Martin C, Manzullo E, Rubenstein E. Outcomes of Oral Mucositis among Cancer Patients 10, 2002. e-Pub 2002.
- Grover T S, Martin C, Benjamin R, Ewer M, Escalante C, Manzullo E, Elting L. A Cost-Effectiveness Analysis of Continuous Infusion of Doxorubicin in the Prevention of Cardiomyopathy Related Morbidity and Mortality:444a, 2000. e-Pub 2000.
- Escalante C, Martin C, Rivera E, Pisters K, Truong M, Manzullo E, Weiser M, Rubenstein E, Elting L. Validation of a Model from Predicting Imminent Death in Acutely Ill Cancer Patients with Dyspnea:527a, 1999. e-Pub 1999.
- Weiser M, Martin C, Escalante C, Rubenstein E, Manzullo, E, Kurtin, D, Elting L. Evaluation of a New Functional Status Scale as a Predictor of complications in Acutely Ill Cancer Patients:418a, 1999. e-Pub 1999.
- Manzullo E, Grover T, Rubenstein E, Martin C, Rolston K, Chambers M, Toth B, Elting L. Infection and Colonization Associated with Oral and Gastrointestinal Mucositis in Patients with Cancer 7:0-17, 1999. e-Pub 1999.
- Manzullo E, Hamill RJ, Tweardy DJ, Sembera CA, Lahoti A, Odaro O, Faiz SA. Preparing For The Future: Outcomes of An Oncologic Focused Internal Medicine Residency Program. MASCC.
Book Chapters
- Manzullo EF, Hwang J, Weed H. Preoperative Management of Patients with Cancer. In: Up to Date, 2003.
- Manzullo EF, Rhines L, Forman A. Neurologic Emergencies. In: Oncologic Emergencies. B.C. Decker Inc, 270-280, 2002.
- Manzullo EF, Welsh GA, Ross DS. Nonthyroid surgery in the patient with thyroid disease. In: Up to Date, 2001.
- Manzullo E, Weber R. Pre-operative Assessment. In: Essentials of Head and Neck Oncology. Thieme Medical Publishers Inc, 89-95, 1998.
Books (edited and written)
- Yeung S, Manzullo EF, Chaftari P, Sandler A. Oncologic Emergencies. Ed(s) 4th. McGraw-Hill Education, 2022.
- Manzullo EF, Gonzalez CE, Escalante CP, Yeung SJ. Oncologic Emergencies In: MD Anderson Cancer Center Series. Ed(s) First. Springer, 2016.
- Yeung SC, Escalante CP, Manzullo EF, Gagel RF. Medical Care of Cancer Patients. People's Medical Publishing House, 2009.
Patient Reviews
CV information above last modified September 08, 2026